I believe investing in ASX shares is one of the best decisions that Aussies can make. However, I wouldn't invest in every ASX share.
There are certain sectors and types of businesses that I'd avoid investing in for my own portfolio. It's not because I don't think they can be good investments, but they don't match with how I want to invest or think about my investments.
My investment style may not be the same as yours. However, it works for me and I think it's worthwhile to consider what strategy would work for every investor, whether that's exchange-traded funds (ETFs) or individual ASX shares.
Let's get into what my dealbreakers are.
I'm not an industry expert in areas like retail or mining, but I think the operations and understanding what makes them succeed are understandable to me.
However, there are some sectors that I view as hard to read on what will help them become successful/maintain success. It can also be difficult to understand how competitors may be impacting the ASX share's market position too.
For me, as a main example, I'm avoiding ASX biotech shares such as CSL Ltd (ASX: CSL) and Telix Pharmaceuticals Ltd (ASX: TLX). They may have great futures, but challenges to existing healthcare products and the potential success of products in the pipeline are hard for me to gauge.
There are a lot of businesses that Aussies can choose from.
Some businesses seem capable of growing profit every year – they can seem very attractive.
Other businesses may be going through a cyclical weak point and they may be likely to grow profit as conditions improve in the next few years. I think they can also make compelling medium-to-longer-term investments.
I think it can be dangerous to try to invest in businesses that are seeing long-term declines. Something being cheap doesn't necessarily mean it's going to turn things around. Some may be able to pull something off, but there's a high chance that it won't.
I like investing in growing ASX shares, but I wouldn't want to overpay at a price that doesn't make sense when taking into account a company's future.
Sometimes, a company's valuation can get ahead of itself and go beyond the prospects of what a business can achieve.
I think the market correction since February – which valuations have only partially recovered from – was healthy for the ASX share market.
But, I wouldn't buy something just because it has gone up a lot. At some point, those valuations can go through a significant reduction to more normal levels, as we've seen over the past two or three months.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。